2652 — CF PharmTech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$2.31bn
- HK$2.04bn
- CNY607.75m
Annual cashflow statement for CF PharmTech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -70.6 | 22.4 | 19.2 | -13.4 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 2.54 | 9.55 | 5.19 | 19.4 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 74.6 | 30.1 | 11.9 | -181 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 45.5 | 116 | 96.5 | — |
| Capital Expenditures | -121 | -138 | -201 | — |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -30.8 | 10.7 | 87.2 | -4.13 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -151 | -128 | -113 | — |
| Financing Cash Flow Items | -1.4 | -8.58 | -20.3 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -5.41 | 7.88 | 28.7 | — |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -108 | -4.23 | 11.3 | — |